Locations
Dublin, Ireland · Leinster, Ireland
industry
Health · Manufacturing
Size
11-50 employees
Stage
Series B
founded in
2016
CroíValve is an early stage medical device company based in Dublin, Ireland, focused on developing a minimally invasive solution for severe Tricuspid Regurgitation (TR). The company addresses a significant unmet clinical need, as TR has a higher prevalence than aortic stenosis in individuals over 65 years. Their key product, the CroíValve DUO™ Tricuspid Coaptation Valve System, uniquely combines repair and replacement strategies to effectively tackle the challenges posed by TR. With a strong management team possessing extensive clinical, technical, and commercial experience, CroíValve is positioned to make a significant impact in the structural heart market, particularly as they expand their clinical evidence through studies like the TANDEM II Early Feasibility Study.
Something looks off?